Perrigo Company PLC (NYSE:PRGO) Director Acquires $187,880.00 in Stock

Share on StockTwits

Perrigo Company PLC (NYSE:PRGO) Director Theodore R. Samuels II acquired 4,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was purchased at an average cost of $46.97 per share, for a total transaction of $187,880.00. Following the transaction, the director now owns 8,236 shares in the company, valued at $386,844.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

NYSE:PRGO opened at $45.67 on Friday. The company has a market cap of $6.50 billion, a PE ratio of 10.04, a P/E/G ratio of 2.88 and a beta of 1.40. Perrigo Company PLC has a twelve month low of $36.28 and a twelve month high of $78.90. The company has a current ratio of 1.92, a quick ratio of 1.14 and a debt-to-equity ratio of 0.54. The company’s 50 day moving average is $50.54 and its two-hundred day moving average is $48.49.

Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 8th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.05. Perrigo had a net margin of 1.87% and a return on equity of 9.57%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the previous year, the firm earned $1.22 EPS. Perrigo’s revenue was down 3.2% compared to the same quarter last year. As a group, analysts expect that Perrigo Company PLC will post 3.95 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 17th. Shareholders of record on Friday, August 30th will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.84%. The ex-dividend date of this dividend is Thursday, August 29th. Perrigo’s payout ratio is 18.46%.

A number of hedge funds and other institutional investors have recently made changes to their positions in PRGO. SRS Capital Advisors Inc. acquired a new stake in Perrigo during the 2nd quarter valued at approximately $25,000. Financial Gravity Wealth Inc. lifted its stake in Perrigo by 15,075.0% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 607 shares of the company’s stock valued at $29,000 after acquiring an additional 603 shares during the period. Parallel Advisors LLC lifted its stake in Perrigo by 833.7% during the 1st quarter. Parallel Advisors LLC now owns 803 shares of the company’s stock valued at $39,000 after acquiring an additional 717 shares during the period. Advisor Group Inc. lifted its stake in Perrigo by 822.2% during the 4th quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock valued at $41,000 after acquiring an additional 962 shares during the period. Finally, Commonwealth Bank of Australia lifted its stake in Perrigo by 295.6% during the 2nd quarter. Commonwealth Bank of Australia now owns 890 shares of the company’s stock valued at $42,000 after acquiring an additional 665 shares during the period. Institutional investors and hedge funds own 85.94% of the company’s stock.

Several analysts have weighed in on PRGO shares. Cantor Fitzgerald dropped their target price on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 12th. SunTrust Banks boosted their target price on shares of Perrigo to $51.00 and gave the stock a “hold” rating in a research report on Monday, May 20th. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 1st. Finally, Wells Fargo & Co reissued a “hold” rating on shares of Perrigo in a research report on Tuesday, July 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $59.50.

Perrigo Company Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

See Also: What is an SEC Filing?

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Meridian Bioscience  Cut to Sell at ValuEngine
Meridian Bioscience Cut to Sell at ValuEngine
Trevena  Raised to “Buy” at Zacks Investment Research
Trevena Raised to “Buy” at Zacks Investment Research
2U  Now Covered by Analysts at William Blair
2U Now Covered by Analysts at William Blair
Aegis Reaffirms Buy Rating for Yield10 Bioscience
Aegis Reaffirms Buy Rating for Yield10 Bioscience
SunOpta, Inc.  Director Acquires $156,748.80 in Stock
SunOpta, Inc. Director Acquires $156,748.80 in Stock
First Majestic Silver Corp.  Senior Officer Sells C$179,375.00 in Stock
First Majestic Silver Corp. Senior Officer Sells C$179,375.00 in Stock


© 2006-2019 Ticker Report